Immuneering (IMRX) Financials: Revenue & Earnings

IMRX price $4.00 +0.17 +4.31%

Ticker
IMRX
Price
$4.00
Change
+0.17 +4.31%
Market cap ?
$258.47M
P/E ?
-3.59
Dividend yield ?
0.00%
Beta ?
0.39
Sector
Healthcare
Industry
Biotechnology

Financials

2019202020212022202320242025
191970923115352079961316952000

Immuneering Corporation is a biopharmaceutical company dedicated to developing novel therapeutic candidates in the fields of oncology (cancer) and neuroscience. Leading its clinical development efforts are two key drug candidates: IMM-1-104, a dual-MEK inhibitor intended for the treatment of various cancers, including pancreatic, melanoma, colorectal, and non-small cell lung cancer, specifically those driven by RAS…

Fair value

IMRX fair value Not meaningful. Price $4.00.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare IMRX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-0.29——
2026-08-05-0.27-0.26——
2026-05-15-0.21-0.30——
2026-03-06-0.18-0.31——
2025-11-12-0.38-0.37——
2025-08-13-0.40-0.40——
2025-05-05-0.42-0.41——
2025-03-20-0.58-0.42——
2024-11-13-0.49-0.54——
2024-08-06-0.47-0.51——
2024-05-07-0.49-0.45——
2024-03-01-0.52-0.48-94.42M—
2023-11-09-0.43-0.51——
2023-08-03-0.43-0.5494.42M—
2023-05-04-0.51-0.54—8.33K
2023-03-06-0.50-0.5845660.00K
2022-11-10-0.49-0.4838.38K153.33K
2022-08-10-0.44-0.5294.42K196.80K
2022-05-10-0.49-0.44183.70K182.00K
2022-03-10-0.42-0.39189.59K535.50K
2021-11-09-0.47-0.61482.13K330.00K
2021-09-09-1.61-1.44660.04K—
2021-07-30-0.46—748.20K—
2020-12-31-0.43—665.08K—
2020-09-30-0.33—682.57K—
2020-06-30-0.27—480.83K—
2020-03-31-0.24—483.05K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-07-16Gengos AndrewBuy650.00K$4.783.11M
2026-07-16Gengos AndrewOther0——
2026-06-23Zeskind Benjamin J.Buy2.40K$4.5610.95K
2026-06-15Hall Brett MatthewBuy6.04K$4.1525.05K
2026-06-11Schall Thomas J.Buy33.35K$4.12137.40K
2026-06-11HAUSMAN DIANABuy33.35K$4.12137.40K
2026-06-11CARPENTER ROBERT JBuy33.35K$4.12137.40K
2026-06-11KEATING LAURIEBuy33.35K$4.12137.40K
2026-06-11Feinberg PeterBuy33.35K$4.12137.40K
2026-03-13Neufeld Leah RBuy3.63K$4.2915.57K
2026-02-03Bookman MichaelBuy176.00K$4.91864.16K
2026-02-03Brakewood Harold EugeneBuy140.00K$4.91687.40K
2026-02-03Hall Brett MatthewBuy344.00K$4.911.69M
2026-02-03Matushansky IgorBuy140.00K$4.91687.40K
2026-02-03Morales MalloryBuy140.00K$4.91687.40K
2026-02-03Neufeld Leah RBuy140.00K$4.91687.40K
2026-02-03Zeskind Benjamin J.Buy688.00K$4.913.38M
2026-01-16Brakewood Harold EugeneBuy5.25K$4.7624.99K
2026-01-15Schall Thomas J.Buy21.64K$4.67101.04K
2026-01-15Hall Brett MatthewBuy2.30K$4.5710.50K
2026-01-13Neufeld Leah RBuy2.63K$4.1510.91K
2026-01-12Feinberg PeterBuy20.00K$4.3586.90K
2026-01-01KEATING LAURIEBuy7.89K$6.5851.90K
2026-01-01Feinberg PeterBuy7.89K$6.5851.90K
2025-10-03Feinberg PeterBuy7.50K$6.6750.02K
2025-10-01Morales MalloryBuy300$6.391.92K
2025-10-01Neufeld Leah RBuy800$6.385.10K
2025-10-01Bookman MichaelBuy1.02K$6.836.97K
2025-09-30Feinberg PeterBuy7.50K$7.0352.73K
2025-09-29Feinberg PeterBuy5.00K$7.1835.90K
2025-09-15Neufeld Leah RBuy11.81K$1.4316.87K
2025-09-15Morales MalloryBuy14.50K$1.4320.70K
2025-09-15Hall Brett MatthewBuy14.88K$1.4321.25K
2025-07-02HAUSMAN DIANABuy3.00K$3.6210.87K
2025-07-02HAUSMAN DIANABuy2.50K$3.608.99K
2025-07-02Neufeld Leah RBuy700$3.572.50K
2025-07-02Zeskind Benjamin J.Buy7.01K$3.5324.79K
2025-07-01Zeskind Benjamin J.Buy2.98K$3.3810.09K
2025-06-27Schall Thomas J.Buy9.50K$3.6634.79K
2025-06-23Hall Brett MatthewBuy6.01K$2.4314.60K
2025-06-20Hall Brett MatthewBuy7.42K$2.7020.02K
2025-06-20Brakewood Harold EugeneBuy1.90K$2.534.80K
2025-06-18Feinberg PeterBuy25.00K$2.5363.19K
2025-06-18Zeskind Benjamin J.Buy21.00K$2.3950.14K
2025-06-17Schall Thomas J.Buy40.48K$2.2189.28K
2025-06-13HAUSMAN DIANABuy33.35K$1.9063.37K
2025-06-13Schall Thomas J.Buy33.35K$1.9063.37K
2025-06-13KEATING LAURIEBuy33.35K$1.9063.37K
2025-06-13Feinberg PeterBuy33.35K$1.9063.37K
2025-06-13CARPENTER ROBERT JBuy33.35K$1.9063.37K
2025-06-13BERMAN ANN EBuy33.35K$1.9063.37K
2025-03-21Matushansky IgorBuy118.00K$1.80212.40K
2025-03-17Matushansky IgorOther0——
2025-02-05Morales MalloryBuy110.00K$1.91210.10K
2025-02-05Neufeld Leah RBuy110.00K$1.91210.10K
2025-02-05Brakewood Harold EugeneBuy100.00K$1.91191.00K
2025-02-05Hall Brett MatthewBuy240.00K$1.91458.40K
2025-02-05Zeskind Benjamin J.Buy480.00K$1.91916.80K
2025-02-05Bookman MichaelBuy110.00K$1.91210.10K
2025-01-01BERMAN ANN EBuy23.48K$2.2051.67K
2025-01-01BERMAN ANN EBuy17.61K$2.2038.75K
2025-01-01Feinberg PeterBuy23.48K$2.2051.67K
2025-01-01KEATING LAURIEBuy23.48K$2.2051.67K
2024-09-15Morales MalloryBuy4.46K$1.627.24K
2024-06-12Schall Thomas J.Buy8.59K$1.5413.23K
2024-06-12KEATING LAURIEBuy33.35K$1.5451.36K
2024-06-12CARPENTER ROBERT JBuy33.35K$1.5451.36K
2024-06-12Feinberg PeterBuy33.35K$1.5451.36K
2024-06-12BERMAN ANN EBuy33.35K$1.5451.36K
2024-06-12HAUSMAN DIANABuy33.35K$1.5451.36K
2024-05-21Bookman MichaelBuy143.00K$3.01430.43K
2024-05-21Bookman MichaelBuy101.12K$3.01304.36K
2024-05-21Bookman MichaelBuy93.00K$3.01279.93K
2024-05-21Bookman MichaelBuy47.30K$3.01142.37K
2024-05-21Bookman MichaelSell93.00K$6.09566.37K
2024-05-21Bookman MichaelSell143.00K$4.25607.75K
2024-05-21Bookman MichaelSell101.12K$15.001.52M
2024-05-21Bookman MichaelSell47.30K$9.66456.92K
2024-05-21Morales MalloryBuy72.00K$3.01216.72K
2024-05-21Morales MalloryBuy60.50K$3.01182.10K
2024-05-21Morales MalloryBuy23.85K$3.0171.79K
2024-05-21Morales MalloryBuy15.00K$3.0145.15K
2024-05-21Morales MalloryBuy10.00K$3.0130.10K
2024-05-21Morales MalloryBuy5.00K$3.0115.05K
2024-05-21Morales MallorySell72.00K$4.25306.00K
2024-05-21Morales MallorySell60.50K$6.09368.44K
2024-05-21Morales MallorySell10.00K$6.3363.30K
2024-05-21Morales MallorySell5.00K$5.4127.05K
2024-05-21Morales MallorySell23.85K$9.66230.39K
2024-05-21Morales MallorySell15.00K$9.55143.25K
2024-05-21Brakewood Harold EugeneBuy165.00K$3.01496.65K
2024-05-21Brakewood Harold EugeneBuy60.50K$3.01182.10K
2024-05-21Brakewood Harold EugeneSell165.00K$9.711.60M
2024-05-21Brakewood Harold EugeneSell60.50K$6.09368.44K
2024-05-21Neufeld Leah RBuy105.00K$3.01316.05K
2024-05-21Neufeld Leah RBuy88.60K$3.01266.69K
2024-05-21Neufeld Leah RBuy60.50K$3.01182.10K
2024-05-21Neufeld Leah RSell60.50K$6.09368.44K
2024-05-21Neufeld Leah RSell88.60K$13.851.23M
2024-05-21Neufeld Leah RSell105.00K$4.25446.25K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 119, holders +18 vs prior quarter. Ownership 78.66%.

HolderSharesChangeChange %Value
FMR LLC9.70M6.67K+0.07%48.43M
BLACKROCK, INC.4.37M2.87M+190.20%21.83M
SANOFI2.71M00.00%13.52M
VANGUARD CAPITAL MANAGEMENT LLC2.29M-1.91K-0.08%11.41M
PRICE T ROWE ASSOCIATES INC /MD/1.94M106.89K+5.84%9.66M
GEODE CAPITAL MANAGEMENT, LLC1.37M732.81K+114.87%6.84M
STATE STREET CORP1.00M733.48K+273.15%5.00M
DCF ADVISERS, LLC790.00K648.54K+458.45%3.94M
MARSHALL WACE, LLP731.90K-1.26M-63.34%3.65M
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.601.25K200.89K+50.18%3.00M
ALETHEA CAPITAL MANAGEMENT, LLC472.94K450.00K+1962.07%2.36M
SUMMIT FINANCIAL, LLC452.26K75.52K+20.04%2.26M
UBS GROUP AG448.86K72.57K+19.29%2.24M
NUVEEN, LLC438.36K438.36KNew2.19M
NORTHERN TRUST CORP436.99K319.33K+271.38%2.18M
LEVIN CAPITAL STRATEGIES, L.P.414.00K404.00K+4040.00%2.07M
CITADEL ADVISORS LLC386.41K366.91K+1881.59%1.93M
VANGUARD FIDUCIARY TRUST CO360.76K38.73K+12.03%1.80M
VANGUARD PORTFOLIO MANAGEMENT LLC359.08K359.08KNew1.79M
GSA CAPITAL PARTNERS LLP343.30K266.55K+347.29%1.71M
MILLENNIUM MANAGEMENT LLC330.40K-772.31K-70.04%1.65M
BURKEHILL GLOBAL MANAGEMENT, LP300.00K00.00%1.50M
TWO SIGMA INVESTMENTS, LP288.42K43.65K+17.83%1.44M
SUSQUEHANNA INTERNATIONAL GROUP, LLP282.50K201.40K+248.34%1.41M
MORGAN STANLEY226.49K-69.58K-23.50%1.13M

Earnings and financials

Immuneering Corporation (IMRX) trades at $4.00, with a market cap of $258.47M and a trailing P/E of -3.59. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2019202020212022202320242025
191970923115352079961316952000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Immuneering (IMRX) Financials: Revenue & Earnings

IMRX$4.00+0.17 +4.31%

$258.47M

Market Cap

-3.59

P/E

—

Forward P/E

—

Score

Price History